Ying, X., Jiang, X., Zhang, H., Liu, B., Huang, Y., Zhu, X., . . . Ji, W. (2020). Programmable N6-methyladenosine modification of CDCP1 mRNA by RCas9-methyltransferase like 3 conjugates promotes bladder cancer development. Mol Cancer.
Chicago Style CitationYing, Xiaoling, et al. "Programmable N6-methyladenosine Modification of CDCP1 MRNA By RCas9-methyltransferase Like 3 Conjugates Promotes Bladder Cancer Development." Mol Cancer 2020.
Cita MLAYing, Xiaoling, et al. "Programmable N6-methyladenosine Modification of CDCP1 MRNA By RCas9-methyltransferase Like 3 Conjugates Promotes Bladder Cancer Development." Mol Cancer 2020.
Atenció: Aquestes cites poden no estar 100% correctes.